Four weeks of near-normalization of blood glucose restores the insulin response to GIP and improves the insulin response to GLP-1 in patients with type 2 diabetes

被引：0
|
作者：
Hojberg, Patricia V.
Vilsbol, Tina
Knop, Filip K.
Bache, Michael
Madsbad, Sten
Krarup, Thure
Holst, Jens J.
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A373 / A373
页数：1
相关论文
共 50 条
  • [21] Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
    Thomas, Melissa K.
    Nikooienejad, Amir
    Bray, Ross
    Cui, Xuewei
    Wilson, Jonathan
    Duffin, Kevin
    Milicevic, Zvonko
    Haupt, Axel
    Robins, Deborah A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02): : 388 - 396
  • [22] Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients
    Thomas, Melissa K.
    Nikooienejad, Amir
    Bray, Ross
    Cui, Xuewei
    Wilson, Jonathan M.
    Duffin, Kevin L.
    Milicevic, Zvonko
    Haupt, Axel
    Robins, Deborah A.
    DIABETES, 2019, 68
  • [23] The Insulin Response to Oral Glucose in GIP and GLP-1 Receptor Knockout Mice: Review of the Literature and Stepwise Glucose Dose Response Studies in Female Mice
    Ahren, Bo
    Yamada, Yuichiro
    Seino, Yutaka
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [24] Effects of variations in duodenal glucose load on glycaemia, insulin and GLP-1 in type 2 diabetes
    Rayner, C. K.
    Ma, J.
    Pilichiewicz, A.
    Feinle-Bisset, C.
    Checklin, H. L.
    Wishart, J. M.
    Jones, K. L.
    Horowitz, M.
    DIABETOLOGIA, 2009, 52 : S105 - S106
  • [25] Decreased insulin secretion in response to glucose and GLP-1 in MODY-3
    Egan, JM
    Clocquet, AR
    Greig, NH
    Hattersley, AT
    Habener, JF
    Tack, CJ
    Elahi, D
    DIABETOLOGIA, 2000, 43 : A17 - A17
  • [26] Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
    Salehi, Marzieh
    Aulinger, Benedict
    Prigeon, Ronald L.
    D'Alessio, David A.
    DIABETES, 2010, 59 (06) : 1330 - 1337
  • [27] Addition of a GLP-1 Agonist to Insulin Therapy in Type 2 Diabetes
    Gavigan, Colleen
    Donner, Thomas W.
    DIABETES, 2021, 70
  • [28] The combination of insulin and GLP-1 analogues in the treatment of type 2 diabetes
    van der Klauw, M. M.
    Wolffenbuttel, B. H. R.
    NETHERLANDS JOURNAL OF MEDICINE, 2012, 70 (10): : 436 - 443
  • [29] GLP-1 receptor agonists and basal insulin in type 2 diabetes
    Young, Laura A.
    Buse, John B.
    LANCET, 2014, 384 (9961): : 2180 - 2181
  • [30] The effect of exogenous GLP-1 on the glucose mediated insulin secretion: A dose-response study in patients with Type 2 diabetes mellitus and control subjects.
    Kjems, LL
    Volund, A
    Madsbad, S
    DIABETOLOGIA, 1999, 42 : A39 - A39
12345